Introducing OpenBioLLM-Llama3-70B & 8B: Saama’s AI Research Lab Released the Most Openly Available Medical-Domain LLMs to Date
Related Posts
Blenrep Shows Promise in DREAMM-7 Phase 3 Trial for Relapsed, Refractory Multiple Myeloma
DREAMM-7 was a Phase 3, multicenter, open-label, randomized trial analyzing the efficacy and safety of Blenrep plus bortezomib and dexamethasone…
Leading with the Patient Voice
In a recent video interview with Applied Clinical Trials, Yael Elish, founder, CEO, StuffThatWorks; and Julie Ross, president, CEO, Advanced…
Phase II Triple Combo Trial of Osemitamab for Gastric/Gastroesophageal Adenocarcinoma Produces Encouraging Results
Image Credit: © PIC4U – stock.adobe.com Transcenta has announced results from the Phase I/IIa Cohort-G data for Osemitamab (TST001) plus…